Kiniksa Pharmaceuticals International PLC (KNSA)
22.03
+0.55
(+2.56%)
USD |
NASDAQ |
Nov 05, 16:00
22.03
0.00 (0.00%)
After-Hours: 18:10
Kiniksa Pharmaceuticals International Max Drawdown (5Y): 75.43% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 75.43% |
| September 30, 2024 | 75.43% |
| August 31, 2024 | 79.15% |
| July 31, 2024 | 83.06% |
| June 30, 2024 | 83.06% |
| May 31, 2024 | 83.06% |
| April 30, 2024 | 83.06% |
| March 31, 2024 | 83.06% |
| February 29, 2024 | 83.06% |
| January 31, 2024 | 83.06% |
| December 31, 2023 | 83.06% |
| November 30, 2023 | 83.06% |
| October 31, 2023 | 83.06% |
| September 30, 2023 | 83.06% |
| August 31, 2023 | 83.06% |
| July 31, 2023 | 83.06% |
| June 30, 2023 | 83.06% |
| May 31, 2023 | 83.06% |
| April 30, 2023 | 83.06% |
| March 31, 2023 | 83.06% |
| February 28, 2023 | 83.06% |
| January 31, 2023 | 83.06% |
| December 31, 2022 | 83.06% |
| November 30, 2022 | 83.06% |
| October 31, 2022 | 83.06% |
| Date | Value |
|---|---|
| September 30, 2022 | 83.06% |
| August 31, 2022 | 83.06% |
| July 31, 2022 | 83.06% |
| June 30, 2022 | 83.06% |
| May 31, 2022 | 83.06% |
| April 30, 2022 | 83.06% |
| March 31, 2022 | 83.06% |
| February 28, 2022 | 83.06% |
| January 31, 2022 | 83.06% |
| December 31, 2021 | 83.06% |
| November 30, 2021 | 83.06% |
| October 31, 2021 | 83.06% |
| September 30, 2021 | 83.06% |
| August 31, 2021 | 83.06% |
| July 31, 2021 | 83.06% |
| June 30, 2021 | 83.06% |
| May 31, 2021 | 83.06% |
| April 30, 2021 | 83.06% |
| March 31, 2021 | 83.06% |
| February 28, 2021 | 83.06% |
| January 31, 2021 | 83.06% |
| December 31, 2020 | 83.06% |
| November 30, 2020 | 83.06% |
| October 31, 2020 | 83.06% |
| September 30, 2020 | 83.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
75.43%
Minimum
Sep 2024
83.06%
Maximum
Nov 2019
82.74%
Average
83.06%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| OPKO Health Inc | 93.32% |
| Ligand Pharmaceuticals Inc | 76.91% |
| Organon & Co | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 19.30 |
| Beta (5Y) | 0.3535 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 54.28% |
| Historical Sharpe Ratio (5Y) | 0.4396 |
| Historical Sortino (5Y) | 0.9502 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.80% |